Intracranial Germinoma in Two Caucasian American Siblings With Autism Spectrum Disorder

J Pediatr Hematol Oncol. 2024 Mar 1;46(2):106-111. doi: 10.1097/MPH.0000000000002821. Epub 2024 Jan 29.

Abstract

Intracranial germ cell tumors (IGCTs) comprise 3% to 5% of all pediatric brain tumors in the West, with a significantly higher prevalence in Asia. Although these tumors are histologically diverse, repeated somatic variants have been demonstrated. Chromosomal aneuploidies, such as Klinefelter and Down syndromes, are associated with IGCTs, but no familial germline tumor syndromes are currently known. Here, we report the novel case of 2 American siblings with underlying autism spectrum disorder who developed intracranial germinoma within months of each other, in the absence of external risk factors. Extensive genetic testing was performed, including karyotyping, chromosomal microarray, and whole exome and whole genome sequencing, and did not identify any variants accounting for the phenotypes. Despite the absence of overlapping variants, a recent retrospective review demonstrated a threefold greater prevalence of autism spectrum disorder in patients with intracranial germinoma compared with national prevalence. This report highlights the complexity of tumor development, as well as the need for further research regarding IGCTs in a neurodivergent population.

Publication types

  • Case Reports

MeSH terms

  • Autism Spectrum Disorder* / genetics
  • Brain Neoplasms* / genetics
  • Brain Neoplasms* / pathology
  • Child
  • Genetic Testing
  • Germinoma* / genetics
  • Humans
  • Siblings